PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
7884426-2	1995	PURPOSE: Here we report the results of a phase II study of teniposide, one of the most active drugs against small-cell lung cancer (SCLC), in patients with brain metastases.	Teniposide	59-69	SCLC1	Homo sapiens	132-136	
7884426-3	1995	PATIENTS AND METHODS: Patients with SCLC who presented with brain metastases at diagnosis (n = 11) or during follow-up evaluation after treatment (n = 69) were treated with teniposide at a dose of 150 mg/m2 intravenously on days 1, 3, and 5 at 3-week intervals in an outpatient setting.	Teniposide	173-183	SCLC1	Homo sapiens	36-40	
7884426-11	1995	CONCLUSION: Teniposide is active against brain metastases of SCLC.	Teniposide	12-22	SCLC1	Homo sapiens	61-65	
1329230-8	1992	Therefore, teniposide is an effective agent against brain metastases of SCLC and is suitable for palliation of these patients.	Teniposide	11-21	SCLC1	Homo sapiens	72-76	
1411638-4	1992	The substantial antitumor activity of teniposide is comparable with that of etoposide, and clinical interest was rekindled when it was shown to have considerable activity against small cell lung cancer (SCLC).	Teniposide	38-48	SCLC1	Homo sapiens	203-207	
1411638-8	1992	Finally, it is suggested that with new routes of administration and improved formulations, teniposide may be expected to play a significant role in the treatment of malignant lymphomas, SCLC, and pediatric lymphocytic leukemia and neuroblastoma.	Teniposide	91-101	SCLC1	Homo sapiens	186-190	
2549879-2	1989	Of new drugs, teniposide and carboplatin have a significant activity against SCLC, however, the usefulness of these drugs must be determined in the comparative fashion with their mother compounds.	Teniposide	14-24	SCLC1	Homo sapiens	77-81	
3815721-1	1987	To determine whether there is any difference between the two epipodophyllotoxin derivatives etoposide and teniposide in their therapeutic effect in small cell carcinoma of the lung (SCCL), they were compared against five human SCCL cell lines in vitro.	Teniposide	106-116	SCLC1	Homo sapiens	182-186